Kane P A, Ayton V, Walters H L, Benjamin I, Heaton N D, Williams R, Karani J B
Department of Radiology, Kings College Hospital, London, UK.
Acta Radiol. 1997 Jul;38(4 Pt 2):650-4. doi: 10.1080/02841859709172396.
To compare lesion detection and characterisation predicted by MnDPDP-enhanced MR imaging with surgical excision and pathological examination.
Ninety patients were intravenously infused at a rate of 2 to 3 ml/min with 5 mumol/kg mangafodipir trisodium (MnDPDP, Teslascan). The patients were examined with spin-echo and gradient-echo T1-weighted MR imaging at 1 h and 24 h after the end of infusion. The results were compared with identical pre-contrast sequences. In 20 of these patients, the pre-operative MR findings were compared with intra-operative ultrasonography and histology of the resected liver specimens.
In those with liver metastases, there was a good correlation between MR and the hepatic disease in 11 out of 14 cases. In the group with primary liver tumours, MR findings correlated with hepatic disease in 5 out of 6 cases.
Liver lesion characterisation is possible with MnDPDP, and MR contrast enhancement with this agent is considered to be an important adjunct to the radiological assessment of patients with neoplastic liver disease where accurate decisions for surgical planning are imperative.
比较锰福地匹三钠增强磁共振成像预测的病变检测及特征与手术切除及病理检查结果。
90例患者以2至3毫升/分钟的速率静脉注射5微摩尔/千克的锰福地匹三钠(MnDPDP,泰乐影)。在注射结束后1小时和24小时,对患者进行自旋回波和梯度回波T1加权磁共振成像检查。将结果与相同的平扫序列进行比较。在其中20例患者中,将术前磁共振成像结果与术中超声检查及切除肝脏标本的组织学结果进行比较。
在肝转移患者中,14例中有11例磁共振成像与肝脏疾病之间存在良好相关性。在原发性肝肿瘤组中,6例中有5例磁共振成像结果与肝脏疾病相关。
使用锰福地匹三钠可以对肝脏病变进行特征描述,并且这种造影剂增强磁共振成像被认为是对患有肿瘤性肝病且必须为手术规划做出准确决策的患者进行放射学评估的重要辅助手段。